Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Refine Results

My entire professional career, beginning from graduation from college, has been focused on fee-for-service analytical services supporting the pharmaceutical and drug development industry on a global basis. My first 13 years were focused on the Good Manufacturing Practice (GMP) analytical services realm supporting laboratory activities that enabled formulation development, finished product testing, manufacturing, and a multitude of regulatory compliant services in this area.  With this experience under my belt, I began to look for opportunities that allowed me to gain experience, expand my knowledge, and support drug development more broadly. My path to bioanalysis: Never afraid of... Read More


ADME , Bioanalytical Laboratories

Authors: Marc Edwards & Victor Weigman As we celebrate the efforts of so many researchers, providers, patients, and advocates on World Diabetes Day, we have much to be excited about today.  New discoveries are being made and new hope is being given to patients living with diabetes across the globe. However, this excitement is tempered by some very sobering statistics: Worldwide prevalence figures estimate that there were 415 million adults living with Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D) in 2015 and that by 2035, this number will have risen to 642 million, especially in middle and low income families.1  Diabetes affects 30 million children and adults in the US (1 in 11... Read More

This month, during World Immunization Week (April 24-30, 2017), we recognize immunizations as one of the world’s most important and effective health interventions, responsible for saving countless people of all ages from disease and death. The theme for 2017 World Immunization Week is #VaccinesWork.  Over the last 3 years, Ebola vaccine research has transitioned from lightly funded research in the public health arena to both biotech companies and large pharma.  New approaches to vaccine design have been brought to the mainstream allowing them to address other emerging and established infectious diseases. Remarkably, new vaccine designs for Ebola are already being applied to the Zika... Read More


Vaccines , Research and Development , End-to-End Services , Central Laboratories